Sigvotatug Vedotin trials for Carcinoma, Non-Small-Cell Lung

All Sigvotatug Vedotin trials · All Carcinoma, Non-Small-Cell Lung trials

Phase breakdown

Recruiting trials studying Sigvotatug Vedotin for Carcinoma, Non-Small-Cell Lung

• A Study of Sigvotatug Vedotin in Advanced Solid Tumors
  NCT04389632 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 158 locations
• Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
  NCT07227298 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 73 locations
• This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
  NCT06758401 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 372 locations

Common questions

How many trials study Sigvotatug Vedotin for Carcinoma, Non-Small-Cell Lung?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.